Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 70576 - 70600 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Silicon dioxide	Approved	FGD6	55785	upregulated	Silicon Dioxide results in increased expression of FGD6 mRNA	12q22	A24196
Silicon dioxide	Approved	FGF1	2246	upregulated	Silicon Dioxide analog results in increased expression of FGF1 mRNA	5q31.3	A24195
Silicon dioxide	Approved	FGF17	8822	upregulated	Silicon Dioxide analog results in increased expression of FGF17 mRNA	8p21.3	A24195
Silicon dioxide	Approved	FGF18	8817	upregulated	Silicon Dioxide analog results in increased expression of FGF18 mRNA	5q35.1	A24194
Silicon dioxide	Approved	FGF2	2247	upregulated	Silicon Dioxide results in increased expression of FGF2 mRNA	4q28.1	A24196
Silicon dioxide	Approved	FGF5	2250	upregulated	Silicon Dioxide results in increased expression of FGF5 mRNA	4q21.21	A24196
Silicon dioxide	Approved	FGFBP1	9982	downregulated	Silicon Dioxide analog results in decreased expression of FGFBP1 mRNA	4p15.32	A24195
Silicon dioxide	Approved	FGFBP3	143282	upregulated	Silicon Dioxide analog results in increased expression of FGFBP3 mRNA	10q23.32	A24195
Silicon dioxide	Approved	FGFR1OP	11116	upregulated	Silicon Dioxide analog results in increased expression of FGFR1OP mRNA	6q27	A24195
Silicon dioxide	Approved	FGFR2	2263	downregulated	Silicon Dioxide analog results in decreased expression of FGFR2 mRNA	10q26.13	A24195
Silicon dioxide	Approved	FGFR2	2263	downregulated	Silicon Dioxide results in decreased expression of FGFR2 mRNA	10q26.13	A24196
Silicon dioxide	Approved	FGFR3	2261	downregulated	Silicon Dioxide analog results in decreased expression of FGFR3 mRNA	4p16.3	A24195
Silicon dioxide	Approved	FGFR4	2264	downregulated	Silicon Dioxide analog results in decreased expression of FGFR4 mRNA	5q35.2	A24195
Silicon dioxide	Approved	FGG	2266	downregulated	Silicon Dioxide analog results in decreased expression of FGG mRNA	4q32.1	A24195
Silicon dioxide	Approved	FGL1	2267	downregulated	Silicon Dioxide analog results in decreased expression of FGL1 mRNA	8p22	A24195
Silicon dioxide	Approved	FGR	2268	upregulated	Silicon Dioxide analog results in increased expression of FGR mRNA	1p35.3	A24194 A24195
Silicon dioxide	Approved	FHAD1	114827	downregulated	Silicon Dioxide analog results in decreased expression of FHAD1 mRNA	1p36.21	A24195
Silicon dioxide	Approved	FHAD1	114827	upregulated	Silicon Dioxide analog results in increased expression of FHAD1 mRNA	1p36.21	A24194
Silicon dioxide	Approved	FHIT	2272	downregulated	Silicon Dioxide results in decreased expression of FHIT mRNA	3p14.2	A24196
Silicon dioxide	Approved	FHOD3	80206	downregulated	Silicon Dioxide results in decreased expression of FHOD3 mRNA	18q12.2	A24196
Silicon dioxide	Approved	FIBCD1	84929	downregulated	Silicon Dioxide analog results in decreased expression of FIBCD1 mRNA	9q34.12	A24195
Silicon dioxide	Approved	FICD	11153	upregulated	Silicon Dioxide analog results in increased expression of FICD mRNA	12q23.3	A24195
Silicon dioxide	Approved	FILIP1	27145	downregulated	Silicon Dioxide analog results in decreased expression of FILIP1 mRNA	6q14.1	A24195
Silicon dioxide	Approved	FILIP1L	11259	upregulated	Silicon Dioxide results in increased expression of FILIP1L mRNA	3q12.1	A24196
Silicon dioxide	Approved	FJX1	24147	upregulated	Silicon Dioxide analog results in increased expression of FJX1 mRNA	11p13	A24195

Displaying entries 70576 - 70600 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability